• All
  • Transaction Details
Healthcare | Corporate Finance Advisory

Immucor Board of Directors Re-Elected

  • Immucor, Inc. (NASDAQ: BLUD) is a leading supplier of diagnostic reagents and automated instrumentation to ensure the safety of blood transfusions
  • Kairos Partners, an 11.6% Immucor shareholder, launched a proxy contest to replace Immucor’s board of directors with an alternative slate of directors
  • TM Capital Corp. served as advisor to Immucor in its successful effort to defeat the dissident slate and re-elect Immucor’s existing directors

The Board of Directors of

has won re-election in a proxy contest against an alternative slate of directors

Immucor Board of Directors Re-Elected

TM Capital advised the Board of Directors of Immucor, Inc.(NASDAQ) in connection with a proxy contest in which all of Immucor’s directors were successfully re-elected

Details

For more information, contact our healthcare team at:

healthcare@tmcapital.com

Client Testimonial

”